The Trump-aligned Kennedy Center board voted to immediately close the institution for renovations, a source familiar with the vote said, after President Trump and his allies on the board repeatedly warned of financial and physical ruin for the center if no action is taken. Earlier Tuesday, a federal judge again blocked the board — which…
The Osher Map Library, at the University of Southern Maine in Portland, is home to half a million rare maps, globes and atlases, dating as far back as the 15th century. Correspondent Martha Teichner explores the world as depicted by cartographers, through maps that are whimsical, political, or intentionally distorted, and examines why – in…
The Emmy Award-winning “CBS News Sunday Morning” is broadcast on CBS Sundays beginning at 9:00 a.m. ET. “Sunday Morning” also streams on the CBS News app beginning at 11:00 a.m. ET. (Download it here.) “Sunday Morning” presents a rebroadcast of its annual edition touching on all aspects of design, hosted by Jane Pauley. Jane Pauley at Ardrossan…
Washington — A federal judge on Thursday pressed lawyers for Ohio Democratic Rep. Joyce Beatty and the Justice Department on new efforts by the John F. Kennedy Center for the Performing Arts’ Board of Trustees to add President Trump’s name back onto the building’s facade. Lawyers for Beatty, who sued last year over Mr. Trump’s…
The Trump administration said it may need to demolish the Kennedy Center if a plan to close the building for two years as part of a controversial renovation project pushed by President Trump and the organization’s board of trustees is blocked by a federal judge. In a Tuesday court filing, the Justice Department said the…
Washington — The Justice Department is scrapping its longtime practice of hiring outside experts to help review and rank competitive grant applications submitted by law enforcement offices, victim services groups and research institutions, a move that some fear could harm the integrity of the selection process and hinder efforts to ensure the money is well-spent,…
Novo Nordisk sued competitor Eli Lilly on Tuesday, alleging the drugmaker engaged in false advertising by claiming its GLP-1 drugs are superior to Novo’s. The lawsuit accuses Eli Lilly of misleading consumers by using outdated clinical trial data to make Zepbound and Mounjaro appear more effective than Novo’s drugs, Wegovy and Ozempic, for weight loss…
